FIL Ltd
Q3 2022 13F-HR Holdings
Net value change ($000)
-6,278,997
(-7.5%)
New positions
100
Sold out positions
59
Turnover %
3.2%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q2 2022
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| IBN | 388,273 | 5210.3% |
| JNJ | 363,031 | 108.0% |
| CNI | 209,030 | 29.4% |
| PDD | 188,276 | 26781.8% |
| AVALARA, INC. | 175,338 | NEW |
| VMWA | 165,641 | 475.6% |
| AEM | 161,600 | 27.4% |
| Global Blood Therapeutics, Inc. | 154,110 | NEW |
| Signify Health, Inc. | 145,371 | NEW |
| V | 140,016 | 36.1% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
14,223
(0.0% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|